Copyright
©The Author(s) 2024.
World J Gastrointest Endosc. Jan 16, 2024; 16(1): 29-36
Published online Jan 16, 2024. doi: 10.4253/wjge.v16.i1.29
Published online Jan 16, 2024. doi: 10.4253/wjge.v16.i1.29
Table 2 Endoscopic operation and follow-up data of two groups, n (%)
Value | Modified group (n = 11) | Conventional group (n = 16) | P value |
Technical success rates | 11/11 (100) | 16/16 (100) | |
Clinical success rates | 10/11 (90.9) | 16/16 (100) | 0.407 |
Operation time (min) | 71.9 ± 11.9 | 22.5 ± 6.7 | < 0.001 |
NBC doses (mL) | 2.0 ± 0.6 | 3.1 ± 1.0 | 0.004 |
Perioperative complications | 1.000 | ||
Ectopic embolization | 0/11 (0) | 0/16 (0) | |
Local venous thrombosis | 0/11 (0) | 0/16 (0) | |
Extravascular injection | 0/11 (0) | 0/16 (0) | |
Severe new-onset bleeding | 0/11 (0) | 1/16 (6.3) | |
Early appearance of glue ulcers | 0/11 (0) | 0/16 (0) | |
Postoperative hospital stay (d) | 4.4 ± 1.6 | 5.8 ± 2.2 | 0.072 |
Recurrent bleeding | 0.624 | ||
Rebleeding in 1 mo | 0/11 (0) | 0/16 (0) | |
Rebleeding in 1-3 mo | 0/11 (0) | 1/16 (6.3) | |
Rebleeding in 4-6 mo | 1/11 (9.1) | 2/16 (12.5) |
- Citation: Zeng Y, Yang J, Zhang JW. Safety and efficacy of modified endoscopic ultrasound-guided selective N-butyl-2-cyanoacrylate injections for gastric variceal hemorrhage in left-sided portal hypertension. World J Gastrointest Endosc 2024; 16(1): 29-36
- URL: https://www.wjgnet.com/1948-5190/full/v16/i1/29.htm
- DOI: https://dx.doi.org/10.4253/wjge.v16.i1.29